A carregar...
Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII bearing tumor cells
Oncolytic herpes simplex virus (HSV) vectors have been used in early phase human clinical trials as a therapy for recurrent malignant glioblastoma. This treatment proved safe but limited improvements in patient survival were observed. The potency of these vectors might be enhanced by targeting vecto...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2923688/ https://ncbi.nlm.nih.gov/pubmed/20508670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2010.22 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|